News

Angioline company took part in EuroPCR2017 congress

ANGIOLINE Company took part in the EuroPCR2017 Congress, the key international course on the interventional medicine. This year it was held on May 16-19, 2017 in Paris. The Company’s products were presented at the exhibition of manufacturers of medical devices within the framework of the Congress.

During the Congress the theme reports of the top-level Russian endovascular surgeons were made. In particular, on EuroPCR2017 Day 1, Dr. M. Chernyaev reported the comparative results of applying the domestic CALIPSO coronary stent and the foreign XIENCE in acute coronary syndrome, while Dr. A. Koledinsky spoke about the successful coronary artery perforation with using bioresorbable stents, on the example of ANGIOLINE’s products.

Particular interest of the Congress participants was attracted by the Session, during which the specialists from Siberia and their colleagues from Serbia shared their experience in performing percutaneous coronary interventions in chronic total occlusion. Of no less interest was the meeting between the Russian and Bulgarian surgeons who discussed the cases of complete revascularization in ST-segment elevation myocardial infarction in patients diagnosed with multiple vascular disease.